Journal of Cardiothoracic Surgery

APRIL 17, 2025

To observe, compare and explore the effect of enhanced extracorporeal counterpulsation (EECP) treatment on cardiac rehabilitation in patients with acute myocardial infarction (AMI) after undergoing percutaneou.

Myocardial Infarction 52

Myocardial Infarction Cardiac Rehabilitation Research 52

Cardiovascular Diabetology

SEPTEMBER 2, 2024

Despite the detrimental impact of abnormal glucose metabolism on cardiovascular prognosis after myocardial infarction (MI), diabetes is both underdiagnosed and undertreated. We investigated associations betwee.

Myocardial Infarction 59

Myocardial Infarction Diabetes Cardiac Rehabilitation Research 59

Journal of the American Heart Association

DECEMBER 14, 2024

BackgroundDespite robust evidence supporting an association with improved outcomes in eligible patients, cardiac rehabilitation (CR) remains underused, with a minority of eligible patients participating. Virtual cardiac rehabilitation (VCR) has been proposed as an alternative to traditional centerbased CR (CBCR) to improve usage rates.

Cardiac Rehabilitation 40

Cardiac Rehabilitation Outcomes Myocardial Infarction Hospital 40

Circulation: Cardiovascular Quality & Outcomes

OCTOBER 19, 2023

BACKGROUND:Although disparities in cardiac rehabilitation (CR) participation are well documented, the role of community-level distress is poorly understood. to −5.6%]), and acute myocardial infarction hospitalization (−1.3% [95% CI, −1.5% to −6.7%]), all-cause hospitalization (−5.9% [95% CI, −6.3%

Cardiac Rehabilitation 40

Cardiac Rehabilitation Inpatient Myocardial Infarction Outcomes 40

Journal of the American Heart Association

FEBRUARY 24, 2025

had an acute myocardial infarction, 17.5% Nearly 65% of beneficiaries had a percutaneous coronary intervention, 33.5% had a coronary artery bypass graft, and 16.8% had a heart valve repair/replacement. Compared with nonparticipants, participants had 47.6

Medicare 45

Medicare Coronary Artery Bypass Graft Cardiac Rehabilitation Inpatient 45

DAIC

FEBRUARY 29, 2024

ET Main Tent (Hall B1) - A Double-blind, Randomized Placebo Procedure-controlled Trial of an Interatrial Shunt in Patients with HFrEF and HFpEF: Principal Results From the RELIEVE-HF Trial - Empagliflozin After Acute Myocardial Infarction: Results of the EMPACT-MI Trial - CSL112 (Apolipoprotein A-I) Infusions and Cardiovascular Outcomes in Patients (..)

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Journal of the American Heart Association

JANUARY 16, 2024

This study is designed to evaluate the Corrie Hybrid CR, a technology‐based, multicomponent health equity‐focused intervention as an alternative to traditional in‐center CR among patients recovering from a cardiac event, surgery, or procedure compared with usual care alone.MethodsThe mTECH‐Rehab (Impact of a Mobile Technology Enabled Corrie CR Program) (..)

Coronary Artery Bypass Graft 40

Coronary Artery Bypass Graft Technology Cardiac Rehabilitation Quality of Life 40